Compare SHG & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHG | CNC |
|---|---|---|
| Founded | 1982 | 1984 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.6B | 33.1B |
| IPO Year | 2003 | 2001 |
| Metric | SHG | CNC |
|---|---|---|
| Price | $81.42 | $61.89 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $46.75 |
| AVG Volume (30 Days) | 112.0K | ★ 3.0M |
| Earning Date | 04-23-2026 | 04-28-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.30 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $5.16 | $8.31 |
| Revenue Next Year | $3.88 | $1.05 |
| P/E Ratio | ★ $9.79 | $11.63 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $47.05 | $31.63 |
| 52 Week High | $85.57 | $69.63 |
| Indicator | SHG | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 39.73 |
| Support Level | $58.52 | $60.86 |
| Resistance Level | $85.57 | $68.67 |
| Average True Range (ATR) | 1.22 | 2.09 |
| MACD | -0.50 | -0.54 |
| Stochastic Oscillator | 38.61 | 4.42 |
Shinhan Financial Group Co Ltd is a Korean banking group. Along with its subsidiaries the company provides, comprehensive financial services which consist of commercial banking services, credit card services, securities services, insurance, credit services, and asset management services, including securities investment trust management, investment advisory, call transaction, domestic and foreign private equity fund business, and other services. The majority of the revenue is generated from its Banking business which includes retail, corporate, international, and other banking services the company offers.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.